The Valley Desk

NCT01472081 · Interventional trial

Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)

Overall registry status Completed

Phase 1

Conditions Clear-cell Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov